CTOs on the Move

Meadow Lawn Nursing Ctr

www.petersenhealthcare.com

 
Meadow Lawn Nursing Ctr is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

The Society of Thoracic Surgeons

The mission of the Society is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy. Learn more at www.sts.org.

Ameronc Inc

Ameronc Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeGift

LifeGift offers hope to the thousands of people in Texas and beyond who need lifesaving organ transplants, and to countless others who need lifesaving tissue transplants. As the designated organ procurement organization (OPO) for North, Southeast and West Texas, we partner with more than 200 hospitals across 109 counties. Established in 1987 as Gulf Coast Independent Organ Procurement Organization, LifeGift is approved by the Centers for Medicare and Medicaid Services (CMS) and accredited by the Association of Organ Procurement Organizations (AOPO) and the American Association of Tissue Banks (AATB).

CMC Rescue Inc

When CMC Rescue was founded in 1978 our mission was to provide rescuers with a knowledgeable source for the specialized equipment they needed to do their jobs. Over the years we have grown to support a wide variety of rescue activities as a leading

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.